InsidersTradesSigma
贝瑞基因: directors' dealings · France · AMF
SZSE:000710FR·AMFMcap 4.0Bn€
Explore the full directors' dealings record of 贝瑞基因, a listed equity based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €4bn. The latest transaction was disclosed on 11 May 2026 — Sale. Among the most active insiders: 高扬. All data is accessible without an account.
5
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
4 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
10.60 €
Income statement
Revenue929.8 M€
Gross profit401.2 M€43% margin
Net income−196.8 M€-21.2% margin
Balance sheet & cash
Market cap3.99 Bn€
Total debt273.2 M€
Free Cash Flow−5.1 M€
Last declaration on 11 May 2026
Declarations5 total
5 of 5 declarations